Search

Your search keyword '"Hansmann, Martin-Leo"' showing total 689 results

Search Constraints

Start Over You searched for: Author "Hansmann, Martin-Leo" Remove constraint Author: "Hansmann, Martin-Leo" Search Limiters Full Text Remove constraint Search Limiters: Full Text
689 results on '"Hansmann, Martin-Leo"'

Search Results

1. Transcriptional reprogramming by mutated IRF4 in lymphoma

4. Imaging bridges pathology and radiology

5. Checkpoint inhibition enhances cell contacts between CD4+ T cells and Hodgkin-Reed-Sternberg cells of classic Hodgkin lymphoma

8. Automated Image Analysis of Hodgkin lymphoma

9. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

10. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

12. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting

14. The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling

15. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

17. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

18. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma

19. Human [CD30.sup.+] B cells represent a unique subset related to Hodgkin lymphoma cells

22. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines

24. Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma

25. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines

26. Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

27. A modular transcriptome map of mature B cell lymphomas

28. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

29. Clonal composition and differentiation stage of human CD30+ B cells in reactive lymph nodes.

30. P043: Molecular pathogenesis of Hodgkin lymphoma

31. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

36. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

37. The genomic and transcriptional landscape of primary central nervous system lymphoma

38. Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group

39. Loss of function mutations of BCOR in classical Hodgkin lymphoma

40. T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma

41. Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma

42. B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens

45. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

47. Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas

48. Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas

49. Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

Catalog

Books, media, physical & digital resources